her tenure at mylan began with this scandal in which it turned out that she had been given -- awardedest virginia university on the basis of doctored transcripts. she didn't do the course work. that mba had to be revoked. it was awarded right after manchin became governor, before he was a senator. there was the scandal around the epipen pricing in which the price was jacked up 400% . under bresch's management, it was handled disastrously. she pulled a marie antoinette on national television, saying nobody is more upset about this than i am, but everybody rightly noted that her compensation has just skyrocketed as mylan ceo. once the morgantown plant got into regulatory trouble with the fda, based on the kinds of data manipulation that some of the executive team had been notably involved in, in their previous employment, they looked to wind down the morgantown plant. the people who are really going to suffer here are american consumers. we need safe medication, affoable medication, and medication made within inspection distance of fda headquarters. that is what the morgantown plant off